XML 33 R24.htm IDEA: XBRL DOCUMENT
v3.26.1

Collaboration and License Agreements (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract] |
Schedule of Revenue by Collaboration Partners | The following table summarizes the revenue by collaboration partner:
| Three Months Ended |  |  | Six Months Ended |
| June 30, |  |  | June 30, |
| 2026 |  |  | 2025 |  |  | 2026 |  |  | 2025 |
| (in thousands) |  |  | (in thousands) |
Amgen | $ | — |  |  | $ | 332 |  |  | $ | — |  |  | $ | 9,818 |
Astellas |  | 79 |  |  |  | 4,646 |  |  |  | 9,072 |  |  |  | 14,093 |
Bristol Myers Squibb |  | — |  |  |  | 11,566 |  |  |  | — |  |  |  | 41,928 |
Regeneron |  | 1,339 |  |  |  | 2,092 |  |  |  | 2,605 |  |  |  | 3,707 |
Moderna |  | — |  |  |  | 22 |  |  |  | — |  |  |  | 29 |
Total revenue | $ | 1,418 |  |  | $ | 18,658 |  |  | $ | 11,677 |  |  | $ | 69,575 |
Summary of Contract Liabilities | The following table presents changes in the Company’s total contract liabilities during the six months ended June 30, 2026 and 2025:
| Deferred Revenue |
| (in thousands) |
December 31, 2025 | $ | 28,467 |
Additions |  | 37,892 |
Revenue recognized |  | (11,669 | )
June 30, 2026 | $ | 54,690 |
December 31, 2024 | $ | 94,063 |
Additions |  | 2,803 |
Revenue recognized |  | (64,575 | )
June 30, 2025 | $ | 32,291 |

X
- Definition Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-10 + Details
Name: | us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration